U.S., Feb. 8 -- ClinicalTrials.gov registry received information related to the study (NCT06814145) titled 'Extension Study of Sotatercept in People With Pulmonary Hypertension (MK-7962-023)' on Feb. 03.
Brief Summary: Researchers are looking for new ways to treat people with a type of pulmonary hypertension called combined postcapillary and precapillary pulmonary hypertension (Cpc-PH). This study focuses on Cpc-PH that is caused by heart failure with preserved ejection fraction (HFpEF).
Researchers want to know if the study treatment, sotatercept, can treat people with Cpc-PH caused by HFpEF. This is an extension study, which means people who took part in a certain study on sotatercept for Cpc-PH (called a parent study) may be able to jo...